First Trust NYSE Arca Biotechnology Index Fund (FBT)

Assets	$2.90B
Expense Ratio	0.55%
PE Ratio	31.38
Forward PE	22.09
Shares Out	11.00M
Dividend	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	n/a
Open	n/a
Previous Close	262.95
Day's Range	n/a
52-Week Low	184.59
52-Week High	275.23
Beta	0.66
Holdings	33
Inception Date	Jun 19, 2006

About FBT

Fund Home Page

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is issued by First Trust.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NYSE Arca
• Ticker Symbol: FBT
• ETF Provider: First Trust
• Index Tracked: NYSE Arca Biotechnology Index

Top 10 Holdings

40.80% of assets

Name	Symbol	Weight
Halozyme Therapeutics, Inc.	HALO	4.84%
Natera, Inc.	NTRA	4.62%
Illumina, Inc.	ILMN	4.51%
Genmab A/S	GMAB	4.02%
Corcept Therapeutics Incorporated	CORT	3.99%
Repligen Corporation	RGEN	3.90%
NeoGenomics, Inc.	NEO	3.78%
Gilead Sciences, Inc.	GILD	3.73%
BeOne Medicines AG	ONC	3.71%
Amgen Inc.	AMGN	3.70%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 13, 2024	$1.1726	Dec 31, 2024
Sep 23, 2015	$0.0197	Sep 30, 2015
Jun 24, 2015	$0.0649	Jun 30, 2015
Mar 25, 2015	$0.0476	Mar 31, 2015
Dec 23, 2014	$0.0524	Dec 31, 2014
Jun 23, 2008	$0.2697	Jun 30, 2008

Performance

FBT had a total return of 45.56% in the past year, including dividends. Since the fund's inception, the average annual return has been 13.75%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Oct 16, 2026

Data Sources Report a data error